186 related articles for article (PubMed ID: 965952)
1. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
Zatz M; Frota-Pessoa O; Levy JA; Peres CA
J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
[TBL] [Abstract][Full Text] [Related]
2. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
Zatz M; Otto PA
Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
[TBL] [Abstract][Full Text] [Related]
4. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
[TBL] [Abstract][Full Text] [Related]
5. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
[TBL] [Abstract][Full Text] [Related]
6. [Carrier detection and gene analysis in a Duchenne muscular dystrophy family].
Lu FM
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):231-3, 255. PubMed ID: 1979269
[TBL] [Abstract][Full Text] [Related]
7. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study.
Hutton EM; Thompson MW
Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964
[TBL] [Abstract][Full Text] [Related]
8. [Modification of the calculation of risk factors in women, possible carriers of Duchenne muscular dystrophy, based on CPK levels].
Villamar López M; Azpeitia González J; Ayuso García C; Fernández García E; Benítez Ortiz J
An Esp Pediatr; 1992 Sep; 37(3):191-4. PubMed ID: 1443913
[TBL] [Abstract][Full Text] [Related]
9. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
Vainzof M; Zatz M; Otto PA
Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
[TBL] [Abstract][Full Text] [Related]
10. Serum myoglobin in muscular dystrophy.
Kagen LJ; Moussavi S; Miller SL; Tsairis P
Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
[TBL] [Abstract][Full Text] [Related]
11. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
Grimm T
Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
[TBL] [Abstract][Full Text] [Related]
12. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
[TBL] [Abstract][Full Text] [Related]
13. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
László A; Salgó L
Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
[No Abstract] [Full Text] [Related]
14. Prospective study of X-linked progressive muscular dystrophy in Campania.
Nigro G; Comi LI; Limongelli FM; Giugliano MA; Politano L; Petretta V; Passamano L; Stefanelli S
Muscle Nerve; 1983 May; 6(4):253-62. PubMed ID: 6683357
[TBL] [Abstract][Full Text] [Related]
15. Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction.
Greenberg CR; Jacobs HK; Halliday W; Wrogemann K
Am J Med Genet; 1991 Apr; 39(1):68-75. PubMed ID: 1867267
[TBL] [Abstract][Full Text] [Related]
16. Experience with DNA analysis in Duchenne and Becker muscular dystrophy families in NSW.
Morgan G; Donald JA; Chen J; Serravalle S; Colley P; Denton MJ
Aust Paediatr J; 1988; 24 Suppl 1():98-9. PubMed ID: 3202741
[TBL] [Abstract][Full Text] [Related]
17. The significance of changes in the blood serum electrolytes in the detection of heterozygous carriers of Duchenne myopathy.
Grinio LP
Sov Genet; 1974 Mar; 7(12):1596-9. PubMed ID: 4827770
[No Abstract] [Full Text] [Related]
18. [Evaluation of the activity of creatine phosphokinase for the detection of carriers of Duchenne-type muscular dystrophy in families in the city of Monterrey, Mexico].
Alvarez Leal M; Ortiz Mariscal JD; Narro Juárez A; Solís Alanís JG; Morales Aguilera A
Rev Invest Clin; 1990; 42(1):39-45. PubMed ID: 2236973
[TBL] [Abstract][Full Text] [Related]
19. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
Muir WA; Knoke J; Martin A; Vignos P; McErlean A
Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
Zatz M; Karp LE; Rogatko A
Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
